© Globe Newswire
23.12.2025
ATAI
LISTED
NASDAQ
AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI)
News Preview
NEW YORK and AMSTERDAM, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Atai Beckley N.V. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting and convenient mental health treatments, today announced its common stock has been added to the NASDAQ...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
23.12.2025
CLBX
LISTED
AIMX
Cellbxhealth PLC Announces Holding(s) in Company
News Preview
GUILDFORD, SURREY / ACCESS Newswire / December 23, 2025 / Cellbxhealth PLC: TR-1: Standard form for notification of major holdings1. Issuer DetailsISINGB0034330679Issuer NameCelLBxHealth plcUK or Non-UK IssuerUK2. Reason for NotificationAn acquisition or disposal of voting rights3. Details of person subject to the notification obligationNameConifer...
Themefolio
Profiler
Peergroup
© BusinessWire
22.12.2025
ASRT
LISTED
NASDAQ
Assertio Holdings, Inc. Announces 1-for-15 Reverse Stock Split
News Preview
Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that it filed a certificate of amendment to its certificate of incorporation (the “Certificate of Amendment”) on December 19 to implement a one-for-fifteen reverse split of its issued and outstanding common stock (the “Reverse Split”).
The Reverse Split will bec...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© PR Newswire
22.12.2025
AMRX
LISTED
NASDAQ
mAbxience and Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA®
News Preview
MADRID, Dec. 22, 2025 /PRNewswire/ -- mAbxience, a Fresenius Kabi majority-owned group with partial ownership from Insud Pharma, and Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company") (NASDAQ: AMRX), today announced that the U.S. Food and Drug Administration (FDA) has approved its Biologics Licensing Applications (BLAs) for Boncresa™ (denosu...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
22.12.2025
AMRX
LISTED
NASDAQ
mAbxience und Amneal geben FDA-Zulassung für Denosumab-Biosimilars unter Bezugnahme auf Prolia® und XGEVA® bekannt
News Preview
MADRID, 22. Dezember 2025 /PRNewswire/ -- mAbxience, eine mehrheitlich im Besitz von Fresenius Kabi und teilweise im Besitz von Insud Pharma befindliche Unternehmensgruppe, und Amneal Pharmaceuticals, Inc. („Amneal" oder das „Unternehmen") (NASDAQ: AMRX) gaben heute bekannt, dass die US-amerikanische Arzneimittelbehörde FDA (Food and Drug Administ...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.12.2025
AMRX
LISTED
NASDAQ
Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA®
News Preview
BRIDGEWATER, N.J., Dec. 22, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (NASDAQ: AMRX) and mAbxience, a Fresenius Kabi majority-owned group with partial ownership from Insud Pharma, today announced that the U.S. Food and Drug Administration (FDA) has approved its Biologics Licensing Applications (BLAs) for Bo...
Themefolio
Profiler
Peergroup
© EQS Newswire
22.12.2025
GXI
LISTED
XETR
Gerresheimer AG corrects comprehensively revenues from bill-and-hold agreements
News Preview
Gerresheimer AG corrects comprehensively revenues from bill-and-hold agreements
Duesseldorf, December 22, 2025. The Management Board of Gerresheimer AG (ISIN: DE000A0LD6E6, “Gerresheimer”) today decided to correct all revenues from bill-and-hold agreements recognized in the 2024 consolidated financial statements in the amount of approximately EUR ......
Themefolio
Profiler
Peergroup
© EQS Newswire
22.12.2025
GXI
LISTED
XETR
Gerresheimer korrigiert umfassend Umsätze aus Bill-and-Hold-Vereinbarungen
News Preview
Gerresheimer korrigiert umfassend Umsätze aus Bill-and-Hold-Vereinbarungen
Düsseldorf, 22. Dezember 2025. Der Vorstand der Gerresheimer AG (ISIN: DE000A0LD6E6, "Gerresheimer"), hat heute beschlossen, sämtliche im Konzernabschluss 2024 gebuchten Umsätze aus Bill-and-Hold-Vereinbarungen in Höhe von rund 28 Mio. Euro zu korrigieren.
Die Gerresheime......
Themefolio
Profiler
Peergroup
© Globe Newswire
22.12.2025
ORY
LISTED
BME
ORYZON Expands Global Patent Protection for Iadademstat with Grant Decision in Japan Covering Combinations with PD-1/PD-L1 Inhibitors
News Preview
Key combination for the treatment of Small Cell Lung Cancer Key combination for the treatment of Small Cell Lung Cancer...
Themefolio
Profiler
Peergroup
© PR Newswire
22.12.2025
INDV
LISTED
NASDAQ
Indivior Announces Inclusion in the S&P SmallCap 600® Index
News Preview
RICHMOND, Va., Dec. 22, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq: INDV) ("Indivior PLC" or the "Company") today announced that it will be added to the S&P SmallCap 600® index, effective today.
"Indivior's inclusion in the S&P...
Themefolio
Profiler
Peergroup
© PR Newswire
22.12.2025
NUTX
LISTED
NASDAQ
NUTEX HEALTH OPENS ARCHVIEW ER & HOSPITAL IN ST. LOUIS
News Preview
HOUSTON, Dec. 22, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 26 state-of-the-art micro hospitals and hospital outpatient departments in 12 states and primary care-centric, risk-bearing physician networks, today announced the opening of...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.12.2025
KDEV
LISTED
STO
Karolinska Development’s portfolio company SVF Vaccines plans for listing on Nasdaq First North Premier through reverse takeover ahead of accelerated vaccine development
News Preview
STOCKHOLM, Sweden, December 22, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company SVF Vaccines has signed a non-binding letter of intent (LOI) with Novakand Pharma AB (“Novakand”) regarding a reverse takeover. Subject to the parties entering into a final agreement and the transaction being approved at Nov...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
21.12.2025
INSP
LISTED
NYSE
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Inspire Medical Systems
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Inspire Medical Systems, Inc. (“Inspire Medical” or the “Company”) (NYSE: INSP) and reminds investors of the January 5, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Com...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.12.2025
ZEAL
LISTED
CPH
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
News Preview
Company announcement – No. 26 / 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
19.12.2025
HNSA
LISTED
STO
Hansa Biopharma Submits BLA to FDA for Imlifidase in desensitization for Kidney Transplantation
News Preview
The application is based on the successful outcome of the pivotal US Phase 3 ConfIdeS trial in highly sensitized patientsImlifidase is an enzyme that rapidly and efficiently cleaves all types of immunoglobulin G (IgG) antibodies both intra- and extra-vascularly to inhibit IgG-mediated immune response FDA has granted Hansa Biopharma Fast Track and...
Themefolio
Profiler
Peergroup
© PR Newswire
19.12.2025
HNSA
LISTED
STO
Hansa Biopharma Submits BLA to FDA for Imlifidase in desensitization for Kidney Transplantation
News Preview
The application is based on the successful outcome of the pivotal US Phase 3 ConfIdeS trial in highly sensitized patientsImlifidase is an enzyme that rapidly and efficiently cleaves all types of immunoglobulin G (IgG) antibodies both intra- and extra-vascularly to inhibit IgG-mediated immune response FDA has granted Hansa Biopharma Fast Track and...
Themefolio
Profiler
Peergroup
© PR Newswire
19.12.2025
AUTL
LISTED
NASDAQ
Immunotherapies Replacing Chemotherapy as Blood Cancer Market to Hit $13B by 2030
News Preview
Issued on behalf of GT Biopharma, Inc.VANCOUVER, BC, Dec. 19, 2025 /CNW/ -- USA News Group News Commentary – The recent FDA approval in November of the first bispecific antibody combination for second-line blood cancer treatment marks the departure from traditional chemotherapy that oncologists have been anticipating for decades[1]. Engineered cel...
Themefolio
Profiler
Peergroup
© PR Newswire
19.12.2025
AUTL
LISTED
NASDAQ
Immunotherapies Replacing Chemotherapy as Blood Cancer Market to Hit $13B by 2030
News Preview
Issued on behalf of GT Biopharma, Inc.VANCOUVER, BC, Dec. 19, 2025 /PRNewswire/ -- USA News Group News Commentary – The recent FDA approval in November of the first bispecific antibody combination for second-line blood cancer treatment marks the departure from traditional chemotherapy that oncologists have been anticipating for decades[1]. Enginee...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.12.2025
IBAB
LISTED
EURONEXT
IBA acquires ORA expanding its strategic leadership in Nuclear Medicine
News Preview
Louvain-La-Neuve, Belgium, 19 December 2025 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology with a preeminent position in nuclear medicine, acquires ORA, a global trailblazer in radiochemistry based in Belgium....
Themefolio
Profiler
Peergroup
© Globe Newswire
19.12.2025
FAGR
LISTED
EURONEXT
Fagron accelerates global expansion with two strategic acquisitions and a key North American licensing milestone
News Preview
Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 19 December 2025 – 7:00 AM CET...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.12.2025
MDGL
LISTED
NASDAQ
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
News Preview
CONSHOHOCKEN, Pa., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it granted equity awards on December 15, 2025 to 4 new non-executive employees as equity inducemen...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.12.2025
GLPG
LISTED
EURONEXT
Galapagos Announces Topline Results from Two Phase 3-Enabling Studies with Selective TYK2 Inhibitor GLPG3667 in Dermatomyositis and Systemic Lupus Erythematosus
News Preview
GLPG3667 met primary endpoint in dermatomyositis study, demonstrating a statistically significant clinical benefit and meaningful improvements on secondary measures of disease activity compared to placebo...
Themefolio
Profiler
Peergroup
© PR Newswire
18.12.2025
TLRY
LISTED
TSX
Canadian Investment Regulatory Organization Trade Resumption - TLRY
News Preview
TORONTO, Dec. 18, 2025 /CNW/ - Trading resumes in:
Company: Tilray Brands, Inc.TSX Symbol: TLRY All Issues: NoResumption (ET): 1:06:29 PMCIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.12.2025
BAVA
LISTED
CPH
Bavarian Nordic Establishes Long-term Incentive Program for Members of Executive Management and Selected Employees
News Preview
COPENHAGEN, Denmark, December 18, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Board of Directors has decided to establish a long-term incentive program for Executive Management as part of the annual remuneration as laid out in the Remuneration Policy, adopted at the annual general meeting. Members of the Executive Management are...
Themefolio
Profiler
Peergroup
© PR Newswire
18.12.2025
TLRY
LISTED
TSX
Canadian Investment Regulatory Organization Trading Halt - TLRY
News Preview
TORONTO, Dec. 18, 2025 /CNW/ - The following issues have been halted by CIRO:
Company: Tilray Brands, Inc.TSX Symbol: TLRY All Issues: NoReason: Single Stock Circuit Breaker Halt Time (ET): 1:01:29 PMCIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented...
Themefolio
Profiler
Peergroup
© BusinessWire
18.12.2025
ERF
LISTED
EURONEXT
Eurofins Scientific: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRA...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.12.2025
COLO B
LISTED
CPH
Coloplast announces changes to Executive Leadership Team
News Preview
Today, Coloplast is announcing changes to the company’s Executive Leadership Team (ELT). The changes relate to the company’s Interventional Urology business as well as the global People & Culture function....
Themefolio
Profiler
Peergroup
© BusinessWire
18.12.2025
SLP
LISTED
NASDAQ
Simulations Plus to Host Virtual Investor Day Highlighting Strategy for the Next Era of Model-Informed Drug Development
News Preview
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced that it will host a virtual Investor Day on Wednesday, January 21, 2026.
The event will offer investors and analysts an in-depth look at the Company’s...
Themefolio
Profiler
Peergroup
© BusinessWire
18.12.2025
DFTX
LISTED
NASDAQ
MindMed to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that Rob Barrow, Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, Jan...
Themefolio
Profiler
Peergroup
© PR Newswire
18.12.2025
ACB
LISTED
NASDAQ
Aurora Launches Daily Special™ in Germany, Delivering High-Quality, Affordable Medical Cannabis to Patients
News Preview
NASDAQ | TSX: ACBDaily Special™ launch expands Aurora's leading portfolio of medical cannabis products available in the company's fastest growing market EDMONTON, AB, Dec. 18, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces the launch of Daily Special™, a ne...
Themefolio
Profiler
Peergroup
© PR Newswire
18.12.2025
ACB
LISTED
NASDAQ
Aurora Launches Daily Special™ in Germany, Delivering High-Quality, Affordable Medical Cannabis to Patients
News Preview
NASDAQ | TSX: ACBDaily Special™ launch expands Aurora's leading portfolio of medical cannabis products available in the company's fastest growing market EDMONTON, AB, Dec. 18, 2025 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces the launch of Daily Special™, a new medic...
Themefolio
Profiler
Peergroup
© ActuNews
17.12.2025
OXUR
LISTED
EURONEXT
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
News Preview
Leuven, BELGIË – 17 december 2025 – 18u00 CET Oxurion NV (Euronext Brussel: OXUR), een bedrijf met hoofdkantoor in Leuven, België, heeft vandaag aangekondigd dat het, in overeenstemming met de Belgische transparantiewetgeving1, de volgende transparantiekennisgeving heeft ontvangen:
Oxurion ontving een transparantiekennisgeving...
Themefolio
Profiler
Peergroup
© ActuNews
17.12.2025
OXUR
LISTED
EURONEXT
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
News Preview
Leuven, BELGIUM – December 17, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received a transparency notification as follows:
Oxurion received a transparency notification on December 16, 2025, from Atlas Special Op...
Themefolio
Profiler
Peergroup
© PR Newswire
17.12.2025
INDV
LISTED
NASDAQ
New Study Shows Extended-Release Buprenorphine Safely Delivers Rapid, Clinically Meaningful Reductions in Opioid Use and Supports Abstinence in High-Risk Populations
News Preview
Both monthly maintenance doses (100 mg and 300 mg) improved opioid abstinence and were well-tolerated with no new safety signals identified.Post-hoc analyses indicated the 300-mg monthly maintenance dose performed significantly better than the 100-mg monthly dose in participants reporting high-frequency fentanyl use.RICHMOND, Va., Dec. 17, 2025 /P...
Themefolio
Profiler
Peergroup
© BusinessWire
17.12.2025
ERF
LISTED
EURONEXT
Eurofins Scientific: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY...
Themefolio
Profiler
Peergroup
© BusinessWire
17.12.2025
SLP
LISTED
NASDAQ
Simulations Plus Announces First Quarter Fiscal Year 2026 Earnings and Conference Call Date
News Preview
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”, “SLP”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced that it will report first quarter fiscal 2026 financial results after the market close on Thursday, January 8, 2026.
Management will host a conference call that...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.12.2025
LEGN
LISTED
NASDAQ
Legend Biotech to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
SOMERSET, N.J., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Ying Huang, Ph.D., the company’s Chief Executive Officer, will present the latest company updates at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on Wednesda...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.12.2025
TRAW
LISTED
NASDAQ
Traws Pharma Reports Positive Interim Clinical Data with Ratutrelvir Versus PAXLOVID™, Shows Activity in PAXLOVID-Ineligible COVID-19 Patients
News Preview
Ratutrelvir shows a differentiated profile versus PAXLOVID™ with fewer adverse events and no viral rebounds...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.12.2025
BAVA
LISTED
CPH
Heidi Hunter Appointed New Vice Chair of the Board of Directors of Bavarian Nordic
News Preview
Heidi Hunter Appointed New Vice Chair of the Board of Directors of Bavarian Nordic...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.12.2025
DBV
LISTED
EURONEXT
DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years
News Preview
Châtillon, France, December 16, 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
16.12.2025
VITR
LISTED
STO
Vitrolife announces genetic services restructuring program targeting annualised savings of 65 MSEK and recognises a 5.4 BSEK goodwill impairment
News Preview
GOTHENBURG, Sweden, Dec. 16, 2025 /PRNewswire/ -- Vitrolife AB (publ) ("Vitrolife") today announced that following a strategic review it will execute a restructuring program of its genetic services business. The program is targeting annualised savings of SEK 65 million, expected to have a positive impact in the first half of 2026, and to reach ful...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.12.2025
EAPI
LISTED
EURONEXT
Market update
News Preview
Paris – December 16, 2025 - EUROAPI announced today that its main shareholders, Sanofi and EPIC Bpifrance, have agreed to extend further the duration of their lock-up until December 18, 2026, subject to customary exceptions. This extension strengthens the stability of EUROAPI’s shareholding structure throughout the execution of its FOCUS-27 plan....
Themefolio
Profiler
Peergroup
© BusinessWire
16.12.2025
BAYN
LISTED
XETR
Introducing Sivanto Energy: Enhanced Flea Beetle Control
News Preview
Bayer Crop Science Canada is excited to announce the launch of Sivanto® Energy, a groundbreaking foliar insecticide designed to deliver swift, reliable pest control with extended protection. Formulated to deliver two highly effective modes of action, Sivanto Energy combines the strengths of deltamethrin and flupyradifurone to provide unparalleled...
Themefolio
Profiler
Peergroup
© BusinessWire
16.12.2025
HLN
LISTED
LSE
Glasgow Caledonian University to Lead £2.6m UK Doctoral Training Programme to Tackle Global Oral Health Challenges
News Preview
Glasgow Caledonian University has secured £2.6 million to lead a major new UK-wide doctoral training programme to spearhead research into oral health and dental disease prevention.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251216404233/en/
Funded by the Biotechnology and Biological...
Themefolio
Profiler
Peergroup
© PR Newswire
16.12.2025
NKTR
LISTED
NASDAQ
REZOLVE-AA Phase 2b Study of Rezpegaldesleukin Establishes Proof-of-Concept in Patients with Severe-to-Very-Severe Alopecia Areata
News Preview
Achieved target product profile on the primary endpoint, with a mean percent reduction in SALT score at 36 weeks of 28.2% in the 24 µg/kg arm versus 11.2% in placebo Mean percent reduction in SALT scores at 36 weeks was 30% for both treatment arms versus 6% for placebo, achieving statistical significance (p<0.05) when excluding four patients th...
Themefolio
Profiler
Peergroup
© BusinessWire
16.12.2025
OGI
LISTED
NASDAQ
Organigram Reports Record Fourth Quarter and Fiscal 2025 Results
News Preview
Organigram Global Inc (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 recreational cannabis company by market share2, is pleased to announce record results for the fourth quarter and twelve months ended September 30, 2025 (“Q4 Fiscal 2025” or "Fiscal 2025"). All financial information in this press release is expressed in Can...
Themefolio
Profiler
Peergroup
© EQS Newswire
16.12.2025
SOON
LISTED
SIX
Sonova stärkt ihr digitales Gesundheitsportfolio durch SilentCloud™-Akquisition und treibt integrierte Hörversorgung voran
News Preview
Sonova Holding AG
/ Schlagwort(e): Ankauf
Sonova stärkt ihr digitales Gesundheitsportfolio durch SilentCloud™-Akquisition und treibt integrierte Hörversorgung voran
16.12.2025 / 07:00 CET/CEST
Group Media & Investor Release
Stäfa (Schweiz), 16. Dezember 2025 – Sonova, ein führender Anbieter innovativer Hörlösungen, ......
Themefolio
Profiler
Peergroup
© EQS Newswire
16.12.2025
SOON
LISTED
SIX
Sonova strengthens digital health portfolio with SilentCloud™ acquisition, advancing integrated hearing care
News Preview
Sonova Holding AG
/ Key word(s): Acquisition
Sonova strengthens digital health portfolio with SilentCloud™ acquisition, advancing integrated hearing care
16.12.2025 / 07:00 CET/CEST
Group Media & Investor Release
Stäfa (Switzerland), December 16, 2025 – Sonova, a leading provider of innovative hearing solutions, tod......
Themefolio
Profiler
Peergroup
© PR Newswire
16.12.2025
NKTR
LISTED
NASDAQ
Nektar to Hold Conference Call to Discuss Topline Results from the 36-Week Induction Treatment Period for its REZOLVE-AA Phase 2b Study of Rezpegaldesleukin in Alopecia Areata on December 16, 2025
News Preview
SAN FRANCISCO, Dec. 15, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR), a clinical-stage biotechnology company focused on development of novel immunology therapies, today announced it will host an investor call and live webcast to review topline results from the 36-week induction treatment period in the ongoing Phase 2b REZOLVE-AA clinica...
Themefolio
Profiler
Peergroup
© BusinessWire
15.12.2025
DFTX
LISTED
NASDAQ
MindMed Announces New Employee Inducement Grant
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the issuance of inducement grants to two newly hired non-executive employees consisting of options to purchase an aggregate of 31,500 common s...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.12.2025
MDGL
LISTED
NASDAQ
Madrigal Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
CONSHOHOCKEN, Pa., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today announced that the company will participate in the J.P. Morgan Annual Healthcare Conference on Monday, January 12, 2026 at 1:30pm PST....
Themefolio
Profiler
Peergroup
© BusinessWire
15.12.2025
ERF
LISTED
EURONEXT
Eurofins Scientific: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRA...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.12.2025
ORY
LISTED
BME
ORYZON Announces the Voting Results of December 2025 Extraordinary General Shareholders' Meeting
News Preview
MADRID and CAMBRIDGE, Mass., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and global leader in epigenetics, today announced the results of voting at the Extraordinary General Shareholders' Meeting held last Friday in Madrid. A total of 33,581,589 of the Company's...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.12.2025
ORNBV
LISTED
HEL
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS15 December 2025 at 14.30 EET ...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.12.2025
IBAB
LISTED
EURONEXT
Proton Therapy New Standard of Care for Patients with Oropharyngeal Cancer
News Preview
Louvain-La-Neuve, Belgium, December 15, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, is pleased to share today that, on December 11, The Lancet – one of the world’s most renowned academic journals – p...
Themefolio
Profiler
Peergroup
© PR Newswire
13.12.2025
SOBI
LISTED
STO
Sobi to acquire Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout
News Preview
Expands Sobi's pipeline with a highly differentiated new Phase 3 asset in GoutAcquisition expected to be highly accretive to Sobi's mid- to long-term growth and margin trajectorySTOCKHOLM, Dec. 13, 2025 /PRNewswire/ -- Sobi® (STO: SOBI) has entered into a definitive agreement to acquire Arthrosi Therapeutics, Inc. (Arthrosi), a private late-stage...
Themefolio
Profiler
Peergroup
© PR Newswire
13.12.2025
SOBI
LISTED
STO
Sobi to acquire Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout
News Preview
Expands Sobi's pipeline with a highly differentiated new Phase 3 asset in GoutAcquisition expected to be highly accretive to Sobi's mid- to long-term growth and margin trajectorySTOCKHOLM, Dec. 13, 2025 /PRNewswire/ -- Sobi® (STO: SOBI) has entered into a definitive agreement to acquire Arthrosi Therapeutics, Inc. (Arthrosi), a private late-stage...
Themefolio
Profiler
Peergroup
© BusinessWire
12.12.2025
ERF
LISTED
EURONEXT
Eurofins Scientific SE: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRA...
Themefolio
Profiler
Peergroup
© PR Newswire
12.12.2025
SOBI
LISTED
STO
Sobi Receives Positive CHMP Opinion for Aspaveli® (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN
News Preview
Approximately 8,000 people in Europe are living with C3G or primary IC-MPGN If approved, Aspaveli (pegcetacoplan) would be the first C3G and primary IC-MPGN treatment for patients 12 and olderSTOCKHOLM, Dec. 12, 2025 /PRNewswire/ -- Sobi® (STO: SOBI) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Me...
Themefolio
Profiler
Peergroup
© PR Newswire
12.12.2025
SECT_B
LISTED
STO
Sectra's six-month interim report 2025/2026: Growth and increased profitability driven by customer satisfaction
News Preview
LINKÖPING, Sweden, Dec. 12, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) reported high order bookings, increased sales and profitability in the first half of 25/26. High levels of customer satisfaction resulted in new and expanded customer commitments, helping to further strengthen Sectra's m...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
